|
Jul 17
|
Ligand Pharmaceuticals Stock Earns 84 RS Rating
|
|
Jul 16
|
3 Stocks That Might Be Undervalued And Present An Investment Opportunity
|
|
Jul 16
|
First Solar And 2 Additional Stocks That May Be Priced Below Estimated Value
|
|
Jul 14
|
3 Stocks That May Be Trading Below Estimated Value In July 2025
|
|
Jul 14
|
3 Stocks Estimated To Be Trading At A Discount Of Up To 25.8%
|
|
Jul 12
|
Top 3 small-cap stock picks while navigating trade uncertainty
|
|
Jun 17
|
Incyte And Two Other Stocks That May Be Priced Below Their Estimated Value
|
|
May 1
|
Ligand to Participate in May Investor Conferences
|
|
Feb 13
|
Ligand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
|
|
Oct 9
|
Ligand Pharmaceuticals Inc (LGND) Q2 2024 Earnings Call Highlights: Robust Revenue Growth Amid ...
|
|
Oct 9
|
LGND: Initiating Coverage – A Prince Among Royalty
|
|
Aug 27
|
Insider Sale: President & COO Matthew Korenberg Sells 18,858 Shares of Ligand ...
|
|
Aug 10
|
Insider Buying: CEO Todd Davis Acquires Shares of Ligand Pharmaceuticals Inc (LGND)
|
|
Aug 8
|
Ligand Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 7
|
How These Two Lesser-Known Biotech Names Obliterated Sales Expectations
|
|
Aug 6
|
Ligand: Q2 Earnings Snapshot
|
|
Aug 6
|
Ligand Reports Second Quarter 2024 Financial Results
|
|
Jul 30
|
Hidden Gems Undiscovered Companies with Strong Fundamentals For July 2024
|
|
Jul 30
|
Undiscovered Gems In The United States For July 2024
|
|
Jul 23
|
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
|